Recipient of federal assistance · SAINT LOUIS, MO

SENSEION THERAPEUTICS INC

SENSEION THERAPEUTICS INC received -$6,263 in federal grants and other assistance in FY2026, on 3 actions, −101% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $4.4M.

Assistance · FY2026: -$6,263
New awards: 0
Actions: 3
Since FY2021: $4.4M

UEI: V2KQH21BGKY5
Location: SAINT LOUIS, MO

Businesses

Open in the explorer Federal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

0FY2021
2.1MFY2022
323.5KFY2023
982.2KFY2024
1MFY2025
-6.3KFY2026

By type

Grants-$6,2630.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research-$6,2630.0%

Largest awards

TARGETING LRRC8 SIGNALING TO PREVENT & TREAT ARTERIAL THROMBOSIS IN TYPE 2 DIABETES - PROJECT SUMMARY CARDIOVASCULAR DISEASE (CVD)…$2.3M
93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Aug 30, 2023 – Aug 15, 2026· R44HL169181
OPTIMIZING SWELL1 MODULATORS TO TREAT NON-ALCOHOLIC STEATOHEPATITIS$1.4M
93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Apr 23, 2021 – Mar 19, 2026· R44DK126600
TARGETING SWELL1 SIGNALING TO TREAT OBESITY-INDUCED TYPE 2 DIABETES - PROJECT SUMMARY/ABSTRACT MORE THAN 100 MILLION AMERICANS CURRENTLY…$990.9K
93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Jan 31, 2022 – Mar 18, 2026· R44DK121598

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.